Search for Novartis AG and
    1. 8 hours ago

      HIV/Aids treatments stand out as GSK promises 40-drug pipeline

      GlaxoSmithKline flagged a pipeline of 40 new drugs in advanced clinical trials as it beat market forecasts for the...

    2. July 22, 2015

      Alzheimer’s breakthrough hopes add to promise of pharma revival

      Hopes of a breakthrough against Alzheimer’s disease have been boosted by encouraging clinical trial data from Eli Lilly...

    Special Reports

    1. Corporate Longevity

      The FT launches a global investigation into the mixture of innovation and focus that c...
    2. Innovation in Healthcare

      Health systems around the world face rising demand from an ageing population. More eff...
    Search more Special Reports on this topic.

    1. July 21, 2015

      Novartis chief looks to blockbuster drugs to counter profits drop

      Novartis’s chief executive has urged investors to look beyond the Swiss group’s disappointing second-quarter results...

    2. July 15, 2015

      Celgene: tomorrow’s growth today

      If all goes as planned, $7.2bn will look cheap. That is what US biotech Celgene will pay for Receptos, which will have...

    3. July 12, 2015

      Drugmakers premiere summer blockbusters

      Blockbuster drugs are back. A wave of new multibillion-dollar medicines for heart disease and high cholesterol, added...

    4. June 12, 2015

      Boardroom trades, June 13

      The future is looking bright for Oxford BioMedica , which specialises in gene and cell therapy. The company announced...

    5. June 7, 2015

      Novartis chief backs shake-up in drug pricing

      Pharmaceutical companies must move towards new pricing models based on outcomes for patients if Europe’s cash-strapped...

    6. May 6, 2015

      GSK: Hard choice

      GlaxoSmithKline chief Andrew Witty is taking the right decisions. And he had better be: his company remains in a very...

    7. May 6, 2015

      GSK drops plans for IPO of HIV drugs unit

      GlaxoSmithKline has dropped plans to sell part of its HIV drugs unit and promised to hold its dividend steady for the...

    8. April 26, 2015

      No end in sight to wave of pharma dealmaking

      Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than...

    9. April 23, 2015

      Novartis starts to reap rewards of revamp

      Novartis announced better than expected first-quarter profits on Thursday as it began to show the benefits of a...

    10. April 17, 2015

      Mylan dismisses takeover interest from Teva Pharmaceuticals

      Israel’s Teva Pharmaceuticals is considering a bid to acquire rival generic drugmaker Mylan even as the $33bn US...

    11. April 7, 2015

      Big pharma turns to small biotechs for edge in cancer treatment

      Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category...

    12. March 30, 2015

      UnitedHealth pays $13bn for drug-benefits manager amid deal flurry

      The largest US health insurer is to spend almost $13bn to buy a company that manages prescription medicines for 35m...

    13. March 29, 2015

      Medics welcome GSK deal to provide meningitis B vaccine

      Patient groups and medics have welcomed an agreement between the government and GlaxoSmithKline to make Britain the...

    14. March 22, 2015

      Apple and Google stake a claim on big pharma’s turf

      Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had...

    15. March 15, 2015

      Pharma sector hails ‘sea change’ in heart disease treatment

      The pharmaceuticals industry has hailed an impending “sea change” in the treatment of heart disease as it gears up to...

    16. March 12, 2015

      GSK to sell Aspen stake for £574m

      GlaxoSmithKline is to halve its stake in South Africa’s Aspen Pharmacare in a move expected to raise £574m. The deal...

    17. March 8, 2015

      Novartis leads way for big pharma cost-cuts

      Novartis is showing the way for big pharmaceutical groups to become more productive, according to its chief executive,...

    18. March 6, 2015

      US regulators approve first biosimilar drug

      US regulators have approved the first of a new class of drugs called biosimilars, which promise to shave billions of...

    19. March 2, 2015

      GSK-Novartis deal ‘a model’ for industry

      A $2bn disposal by Johnson & Johnson and the completion of a $20bn asset swap between GlaxoSmithKline and Novartis on...

    20. March 1, 2015

      Chi-Med poised for China drug milestone

      A UK-listed company backed by Li Ka-shing, one of Asia’s richest men, says it is moving closer to producing the first...

    21. February 25, 2015

      Pharmacyclics considers $19bn sale

      Pharmacyclics is considering a sale that could value the US cancer drugs maker at about $19bn, according to people...

    22. February 6, 2015

      Pharma takes a dose of sense from the deals doctor

      Taking the wrong combination of drugs can have serious side effects. The same goes for pharmaceuticals dealmaking. Mix...

    23. February 4, 2015

      Ackman’s Pershing Square secures seat on Zoetis board

      Bill Ackman, the billionaire hedge fund activist, has parachuted one of his representatives on to the board of Zoetis,...

    24. February 3, 2015

      Novartis faces suspension in Japan over drug trial allegations

      Novartis faces a temporary suspension of its business in Japan as punishment for alleged manipulation of clinical trial...

    25. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    26. January 29, 2015

      Roche and Qualcomm in digital health alliance

      Roche has forged an alliance with Qualcomm to develop remote patient-monitoring systems in the latest sign of digital...

    27. January 27, 2015

      Novartis vows cost cuts after Swiss franc surge

      Novartis has leapt to the defence of the Swiss National Bank for removing the cap on the Swiss franc against the euro...

    28. January 16, 2015

      Swiss surge could boost income investors

      UK investors who hold European and even UK equity income funds stand to benefit from the Swiss National Bank’s decision...

    29. January 15, 2015

      Swiss franc: Bern marks

      It is a rare tsunami that hits a landlocked nation in the mountains of Europe. So the metaphor is an odd choice to...

    30. January 9, 2015

      Small-cap Week, January 10

      Inhaler developer Vectura was among the biggest small-cap gainers this week, amid growing optimism over its royalty...

    31. January 6, 2015

      FDA paves way for biosimilar drug approval

      The US pharmaceuticals watchdog has published a bullish assessment of a copycat biotech drug, paving the way for it to...

    32. December 28, 2014

      Malaria: Real and present danger

      Ka Lar Nar’s fellow east Myanmar villagers chuckle at the story of his periodic headaches because they know he likes...

    33. December 17, 2014

      Juno Therapeutics vies for cancer treatment lead

      When Juno Therapeutics lists on Nasdaq on Friday, it will be one of the biggest events in a big year for the buoyant US...

    34. December 10, 2014

      Emphasis shifts from illness care to well care

      Spire, a small stone-like device less than the size of a walnut, clips on to your belt or bra quietly collecting...

    35. December 10, 2014

      India assumes frontline position in battles over intellectual property rights

      As their cities grow more polluted, more people in India grapple with respiratory difficulties. The Swiss multinational...

    36. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    37. November 7, 2014

      UCB caps week of pharma dealmaking

      UCB of Belgium wrapped up another busy week of pharmaceuticals dealmaking on Friday with the $1.5bn disposal of its US...

    38. FT Alphaville

      October 29, 2014

      This is BABA, what's your target price? [updated]

      First on Alibaba, the FT reports that the Cayman registered derivative contract vaguely related to ecommerce in China —...

    Search for Novartis AG and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Novartis CEO on new growth opportunities...
      July 26, 2015

      Novartis CEO on new growth opportunities

    2. Lex on potential conflict at Swiss drugs group...
      July 17, 2013

      Lex on potential conflict at Swiss drugs group

    3. Lex on Novartis' payment to its outgoing chairman...
      February 18, 2013

      Lex on Novartis' payment to its outgoing chairman